Zantac lawsuits

Zantac’s manufacturers were on a roll. Their defense had exacted a spate of favorable decisions and jury verdicts. Yet, on October 9, Glaxo Smith Kline (GSK) suddenly settled 93% of the remaining cases – for 2.2 billion dollars.

In law, the benefits of bundling come when large numbers of similar cases are grouped together for expeditious resolution by a single judge.